LifeSciences BC > News > Member Announcements > Page 2

Xenon Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter 2019 Financial Results and Provide Corporate Update

April 30, 2019
XENON PHARMACEUTICALS INC.

BURNABY, British Columbia, April 30, 2019 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical-stage biopharmaceutical company, today announced that it will report its first quarter 2019 financial and operating results after the close of U.S. financial markets on Tuesday, May 7, 2019.  Xenon management will host a conference call and live audio webcast at … Continue reading Xenon Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter 2019 Financial Results and Provide Corporate Update

Arbutus to Report First Quarter 2019 Financial Results

April 29, 2019
Arbutus Biopharma Corp.

WARMINSTER, Pa., April 29, 2019 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today announced that it has scheduled its first quarter financial results, conference call and webcast for Monday, May 6, 2019.  The schedule for the press release and conference call/webcast are as follows: • Q1 2019 Press Release: May … Continue reading Arbutus to Report First Quarter 2019 Financial Results

Xenon Pharmaceuticals to Present at the 2019 Bloom Burton & Co. Healthcare Investor Conference

April 24, 2019
XENON PHARMACEUTICALS INC.

BURNABY, British Columbia, April 24, 2019 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical-stage biopharmaceutical company, today announced that Dr. Simon Pimstone, Xenon’s Chief Executive Officer, will present a corporate update at the Bloom Burton & Co. Healthcare Investor Conference in Toronto, Canada on Wednesday, May 1, 2019 at 10:00 am ET. A live … Continue reading Xenon Pharmaceuticals to Present at the 2019 Bloom Burton & Co. Healthcare Investor Conference

LifeSciences BC Announces New President and CEO to Lead Organization

April 15, 2019
LifeSciences BC

 Vancouver, BC – April 15, 2019, Nancy Harrison, Chair, LifeSciences BC Board of Directors, announced today the appointment of Wendy Hurlburt, as the organization’s new President and CEO. “We are very pleased to have Wendy join and lead our team; as she brings a strong business background in pharmaceutical, not-for-profit and operations management to this … Continue reading LifeSciences BC Announces New President and CEO to Lead Organization

Onestep Laboratories received a China patent CN107449902, potential to monitor Chlorine in dialysis for kidney failure

April 10, 2019
Onestep Laboratories Inc.

Onestep Laboratories, a biotech company that specializes in developing and producing raw material for immunoassay and other assays, received a China patent CN107449902, potentially for chlorine monitoring in dialysis for kidney failure. The company is developing a method for chlorine monitoring in dialysis. The current DPD method has many drawbacks. For example, the color produced … Continue reading Onestep Laboratories received a China patent CN107449902, potential to monitor Chlorine in dialysis for kidney failure

WAT Medical Returns Cruise Show with US Partner VIKAND

April 9, 2019
WAT Medical

WAT Medical is a company that develops safe, effective, and user-friendly wearable medical products.  With a team of devoted staff leading in the field of medical research and development, an efficient and convenient medical service is being provided for individual customers worldwide. The mission is supplying innovative self-care medical devices. There are two products on … Continue reading WAT Medical Returns Cruise Show with US Partner VIKAND

First AI Enabled ROI Radiation Reduction Shutter Technology FluoroShield™ Cleared by FDA

April 8, 2019
IKOMED Technologies Inc

Sanford, FL and Vancouver BC, April 2, 2019 – Omega Medical Imaging announces the launch of FluoroShield™FluroroShield in conjunction with technology partner IKOMED Technologies of Vancouver, BC Canada. FluoroShield™ is an Artificial Intelligence powered Region of Interest (ROI) Radiation exposure reduction solution for interventional X-ray imaging available only on Omega’s Flat Panel detector CS-series product … Continue reading First AI Enabled ROI Radiation Reduction Shutter Technology FluoroShield™ Cleared by FDA

DelMar Pharmaceuticals Welcomes Dr. John de Groot, Chairman, ad interim of the Department of Neuro-Oncology at MD Anderson Cancer Center, as founding member of the Company’s Scientific Advisory Board

April 4, 2019
DelMar Pharmaceuticals Inc.

Dr. Napoleone Ferrara, a Member of DelMar Pharmaceuticals Board Will Serve as the Chairman of the SAB VANCOUVER, British Columbia and MENLO PARK, Calif., April 4, 2019 /PRNewswire/ — DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) (“DelMar” or the “Company”), a biopharmaceutical company focused on the development and commercialization of new cancer therapies, announced today the formation of a … Continue reading DelMar Pharmaceuticals Welcomes Dr. John de Groot, Chairman, ad interim of the Department of Neuro-Oncology at MD Anderson Cancer Center, as founding member of the Company’s Scientific Advisory Board

PharmAust successfully reformulates cancer drug

April 3, 2019

April 3, 2019 – ASX-listed biotech PharmAust, has successfully managed to reformulate its potentially breakthrough cancer drug Monepantel after feedback from previous trials that the taste was unpalatable. The reformulation has now cleared the way for new canine clinical trials, a key milestone along the company’s drug development journey that is looking increasingly exciting. In … Continue reading PharmAust successfully reformulates cancer drug

GenXys Health Care Systems announces completion of oversubscribed seed round financing to launch leading precision prescribing software into the US market

April 3, 2019
GenXys

GenXys, a precision prescribing software company tackling a $130 billion global problem, is pleased to announce that it has closed its oversubscribed seed round at $1.77 million, with key investors TYDO and TELUS Ventures. Following early commercial success in Canada, this financing supports GenXys plans to expand into new regions to increase patient safety and medication … Continue reading GenXys Health Care Systems announces completion of oversubscribed seed round financing to launch leading precision prescribing software into the US market